Search clinical trials for: Gadoterate (Dotarem/Clariscan)

Total 81 results

Bayer

Completed

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose (LEADER 75)

Magnetic Resonance Imaging

United States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
Duke University
University of California, San Diego; University of Wisconsin, Madison

Completed

Eovist vs. Dotarem Healthy Volunteer MRI

Transient Severe Arterial Phase Motion

United States
Guerbet
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY)

Cognitive Function | Motor Function | Contrast Media

United States, Korea, Republic of, Italy, Brazil, Canada, Russian Federation
University of Chicago
Guerbet

Completed

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Fibroadenoma

United States
Loyola University
Guerbet

Unknown

Evaluation of Gadoterate in Patients With Decreased Kidney Function

Renal Dysfunction

United States
University of Michigan

Completed

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Liver Tumor

United States
University of Colorado, Denver
National Cancer Institute (NCI); Bracco Diagnostics, Inc

Recruiting

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Colorectal Cancer | Liver Metastases | Oligometastatic Disease

United States
Donna Roberts
National Institute of Standards and Technology

Recruiting

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Magnetic Resonance Imaging | Gadolinium Retention | Gadolinium | MultiHance | Dotarem

United States
Guerbet

Completed

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions (SENTIO)

Central Nervous System Diseases | Diagnostic Self Evaluation

United States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
Guerbet

Completed

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Magnetic Resonance Imaging

France, Austria, Hungary, Poland
Guerbet

Recruiting

Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas (GDX-44-016)

Brain Tumor, Recurrent | Brain Tumor, Primary

Italy, Hungary, Poland
Guerbet

Terminated

DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC (DCE-MRI)

Hepatocellular Carcinoma

Korea, Republic of
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Phoenix Children's Hospital
Guerbet

Completed

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

Brain Diseases

United States
Massachusetts General Hospital
Boehringer Ingelheim

Recruiting

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Interstitial Lung Disease

United States
Guerbet

Completed

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis (ACCREDIT)

Type 2 Diabetes Mellitus | Coronary Atherosclerosis

Korea, Republic of
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Renal Disease

United States
University of Massachusetts, Worcester
Guerbet

Recruiting

Dotarem vs Gadobutrol Contrast for Breast MRI

Breast Diseases

United States
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Completed

Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

Renal Insufficiency

France, Belgium, Spain, Italy
Vanderbilt University Medical Center
Children's Hospital of Philadelphia; Guerbet

Completed

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

Magnetic Resonance Imaging Contrast Agents

United States
Guerbet

Completed

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Contrast-enhanced MRI With Dotarem
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Renal Artery Stenosis

United States
Northwestern University

Completed

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

Vascular Diseases

United States
GE Healthcare

Completed

Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination

Magnetic Resonance Imaging (MRI)

Germany, Norway
Bracco Diagnostics, Inc

Completed

Crossover Comparison of MultiHance and Dotarem (BENEFIT)

Brain Disease

United States
Guerbet

Completed

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

MR Mammography With Dotarem
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Bayer

Completed

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Neoplastic CNS Lesions

Italy
University of Southern California
National Cancer Institute (NCI)

Withdrawn

QSM and Regional DCE MRI Permeability Using GOCART Technique

Intracranial Neoplasm

United States
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
Massachusetts General Hospital

Withdrawn

A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

Contrast Media Allergy

United States
University of Campinas, Brazil
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients

Breast Cancer Female | Doxorubicin Induced Cardiomyopathy

Brazil
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Central Nervous System Diseases | Central Nervous System Neoplasms

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI in Pediatric Patients

Central Nervous System Neoplasms | Central Nervous System Disease
Universitaire Ziekenhuizen KU Leuven

Unknown

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Leiomyomas

Belgium
Cairo University

Unknown

Evaluation of Reliability of CarieScan PRO Compared With Digital Radiograph and ICDAS-II in Detection of Carious Lesions

Dental Caries

Egypt
University of Cincinnati

Unknown

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

Castration-resistant Prostate Cancer | Cancer of the Prostate

United States
Massachusetts General Hospital

Withdrawn

Use of Gadolinium in CT Pulmonary Angiography

Pulmonary Embolism

United States
Bracco Diagnostics, Inc

Terminated

Safety and Efficacy of MultiHance in Pediatric Patients

Central Nervous System Diseases

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Terminated

Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) (MultiGFR)

Kidney Diseases | Renal Insufficiency, Chronic

France
Bracco Diagnostics, Inc

Completed

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries (VALUE)

Carotid, Aortic, Renal or Peripheral Artery Disease

China
Guerbet

Completed

DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

Peripheral Arterial Disease

France
Xiao Chen

Recruiting

Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies

Hepatic Malignancies

China
Technical University of Munich

Completed

Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI (Gadovit)

Subacute/Chronic Myocardial Infarction

Germany
Copenhagen University Hospital at Herlev
Rigshospitalet, Denmark

Unknown

Whole Body Magnetic Resonance Angiography in Ischemic Patients

Atherosclerosis | Intermittent Claudication

Denmark
Lawson Health Research Institute
Bayer

Recruiting

Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer

Liver Metastasis Colon Cancer

Canada
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Flanders Medical Research Program

Completed

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (ROBINSON)

Peripheral Vascular Disease

Belgium

Search clinical trials for: Gadoterate (Dotarem/Clariscan)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations